[stanete]

It doesn't seem that life extension is going to be unreachable for the majority of the people. Look at what happened with DNA sequencing. Anyone can get their DNA sequenced today (yeah, I know some people in very poor countries can't afford it because they don't even have food but hey, you had breakfast today). Comparing with the human genome project, the target price of most drugs that are in clinical trials today is ridiculously low. And it has to be that way because investors wouldn't be interested in those companies. As a biotech/longevity company, you need a reasonable plan on how to market and sell your research. "Immortality is only for the rich" is cyberpunk science fiction.